APA (7th ed.) Citation

R, M., G, N., G, K., EY, K., J, L., EE, A. E., . . . KS, A. (2026). Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies. Molecular therapy. Oncology, 34(2), 201219. https://doi.org/10.1016/j.omton.2026.201219

Chicago Style (17th ed.) Citation

R, Mooney, et al. "Neural Stem Cell Delivery of Oncolytic CRAd-S-pk7 Immunotherapy for Stage 3 Ovarian Cancer: Dose-regimen Studies." Molecular Therapy. Oncology 34, no. 2 (2026): 201219. https://doi.org/10.1016/j.omton.2026.201219.

MLA (9th ed.) Citation

R, Mooney, et al. "Neural Stem Cell Delivery of Oncolytic CRAd-S-pk7 Immunotherapy for Stage 3 Ovarian Cancer: Dose-regimen Studies." Molecular Therapy. Oncology, vol. 34, no. 2, 2026, p. 201219, https://doi.org/10.1016/j.omton.2026.201219.